SPDR Series Trust - SPDR S&P Biotech ETF (NYSEMKT: XBI)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
SPDR Series Trust - SPDR S&P Biotech ETF Return vs. S&P
|1 Year||5 Year||5 Year Annualized||Since IPO|
SPDR Series Trust - SPDR S&P Biotech ETF Company Info
The investment seeks to replicate as closely as possible before expenses the performance of an index derived from the biotechnology segment of a U.S. total market composite index.
News & Analysis
Here are the five best biotech ETFs to invest in right now.
Simplifying your investment strategy can help minimize your risk while still allowing you to earn some great returns.
These ETFs could be big winners in the new year.
Investors wanting to profit from a potential biotech sector bounce should love this exchange-traded fund.
Now's not the best time to bet the farm on anything other than more uncertainty coming up.
Right now, it's even riskier to buy biotechs than normal.
This metric will show you which companies are being valued at potentially unreasonably low levels.
Wall Street seems to have a grudge against the entire sector at the moment.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.